SARomics Biostructures Brings in New Strategic Owners
News Sep 15, 2012
SARomics Biostructures AB has announced that Innovationsbron AB and Lund University Innovation System AB (LUIS AB) are investing in and becoming new co-owners of the company alongside the founders.
The new investment will allow the company to expand its primary business of generating 3D structural information of proteins and protein-ligand complexes.
SARomics Biostructures is a major user of MAX-lab, the Swedish national synchrotron facility in Lund, and aims to position itself as a leading European structural biology service provider when the new world-class MAX IV synchrotron opens in 2015.
Linus Wiebe, CEO of LUIS said “SARomics Biostructures has shown the commercial potential of MAX-lab and we believe that our strategic investment will leverage the company to take full advantage of MAX IV in the future.”
SARomics Biostructures gene-to-structure platform has successfully been applied to determine structures of many important drug targets, biopharmaceuticals, and industrial enzymes for partners from both the life science industry and academia worldwide.
The company is currently expanding its off-the-shelf portfolio of “ready made” crystal structures of important drug targets and will also engage in internal lead discovery programs.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE